Book contents
- Genetically Modified Organisms in Developing CountriesRisk Analysis and Governance
- Genetically Modified Organisms in Developing Countries
- Copyright page
- Contents
- Contributors
- Foreword
- 1 Introduction
- Part I Risk Analysis Methodology and Decision-Making
- Part II Diversification of Expertise
- Part III Risk-Analysis-Based Regulatory Systems
- Part IV Case Studies from Developing Countries
- 18 Risk Regulation of Agricultural GMOs in China: Challenges and Prospects
- 19 Commercial Use and Governance of Bt cotton in China
- 20 The Regulatory Regime for Genetically Modified Crops in India
- 21 The Argentinian GMO Biosafety System: An Evolving Perspective
- 22 The Brazilian GMO Regulatory System: A Historical View and Perspective
- 23 An Effective Regulatory Regime Supported by Research and Development Is Key to Adoption of GM Technology in West Africa: Burkina Faso and Nigeria as Case Studies
- 24 A Pathway for Biosafety Regulation of GMOs in Sub-Saharan Africa
- 25 Conclusions and Recommendations
- Index
- References
24 - A Pathway for Biosafety Regulation of GMOs in Sub-Saharan Africa
from Part IV - Case Studies from Developing Countries
Published online by Cambridge University Press: 05 July 2017
By
Book contents
- Genetically Modified Organisms in Developing CountriesRisk Analysis and Governance
- Genetically Modified Organisms in Developing Countries
- Copyright page
- Contents
- Contributors
- Foreword
- 1 Introduction
- Part I Risk Analysis Methodology and Decision-Making
- Part II Diversification of Expertise
- Part III Risk-Analysis-Based Regulatory Systems
- Part IV Case Studies from Developing Countries
- 18 Risk Regulation of Agricultural GMOs in China: Challenges and Prospects
- 19 Commercial Use and Governance of Bt cotton in China
- 20 The Regulatory Regime for Genetically Modified Crops in India
- 21 The Argentinian GMO Biosafety System: An Evolving Perspective
- 22 The Brazilian GMO Regulatory System: A Historical View and Perspective
- 23 An Effective Regulatory Regime Supported by Research and Development Is Key to Adoption of GM Technology in West Africa: Burkina Faso and Nigeria as Case Studies
- 24 A Pathway for Biosafety Regulation of GMOs in Sub-Saharan Africa
- 25 Conclusions and Recommendations
- Index
- References
Summary
The pathway for biosafety regulation of GMOs in most of sub Saharan Africa is often mired in the controversies around their development and deployment. African governments react differently to these controversies. Some react by developing biosafety regulations that completely deter the advancement of genetically modified organisms; while others are more pragmatic in allowing their biosafety regulatory frameworks to evolve in line with their nation's goal of using gene technology tools to address challenges in health, agriculture and industry. The basic premise of this Chapter is that the apparent contradictions and complexities observed with the development of biosafety regulations across the region can be avoided by positioning biosafety as an integral part of the wider gene technology innovation system. In the latter, the common interest for all actors is the need to ensure that GMOs pose negligible risk to human health and the environment. Therefore, biosafety regulation, viewed as part of the gene technology innovation system, ought to be an inclusive endeavour, which is transparent, impartial and evidence based. In order to achieve this, actor interaction and biosafety regulatory learning should be emphasised.
- Type
- Chapter
- Information
- Genetically Modified Organisms in Developing CountriesRisk Analysis and Governance, pp. 283 - 293Publisher: Cambridge University PressPrint publication year: 2017
References
Adenle, A. A. et al. (2013). Status of development, regulation and adoption of GM agriculture in Africa: views and positions of stakeholder groups. Food Policy 43, 159–166.CrossRefGoogle Scholar
African Union Commission (2014). Science, Technology and Innovation Strategy for Africa 2024. Addis Ababa: African Union Commission.Google Scholar
African Union Commission (2016). Agenda 2063: The Africa We Want. [Online]. Available from http://agenda2063.au.int/en/homeGoogle Scholar
Alexandrova, N. et al. (2005). Biosafety regulations of GMOs: national and international aspects and regional cooperation. Biotechnology & Biotechnological Equipment 19(suppl. 3), 153–172.CrossRefGoogle Scholar
Brinckman, D. (2000). The regulation of rBST: the European case. AgBioForum 3(2–3), 164–172.Google Scholar
Chambers, J. A. (2013). Biosafety of GM Crops in Kenya, Uganda, and Tanzania: An Evolving Landscape of Regulatory Progress and Retreat. Washington, D.C.: Center for Strategic and International Studies.Google Scholar
Cohen, S. N. (2013). DNA cloning: a personal view after 40 years. Proceedings of the National Academy of Sciences of the USA 110(39), 15521–15529.CrossRefGoogle Scholar
Edquist, C. and Johnson, B. (1997). Institutions and organizations in systems of innovation. In Systems of Innovation: Technologies, Institutions and Organizations, ed. Edquist, C. London: Routledge, pp. 41–60.Google Scholar
Etzkowitz, H. (2002). Innovation in innovation: the triple helix of university–industry–government relations. Social Science Information 42(3), 293–337.Google Scholar
Jaffe, G. (2004). Regulating transgenic crops: a comparative analysis of different regulatory processes. Transgenic Research 13, 5–19.CrossRefGoogle ScholarPubMed
Juma, C. (2011). The New Harvest: Agricultural Innovation in Africa. New York, NY: Oxford University Press.Google Scholar
Keese, P. et al. (2002). Seeds of promise: developing a sustainable agricultural biotechnology industry in sub–Saharan Africa. Natural Resources Forum 26(3), 234–244.CrossRefGoogle Scholar
Knight, W. (2002). Zambia bans GM food aid. [Online]. New Scientist Daily News, 30 October 2002. Available from www.newscientist.com/article/dn2990-zambia-bans-gm-food-aid/Google Scholar
Koch, M. (2014). Elements of an enabling biosafety and regulatory environment. In Biotechnology in Africa: Emergence, Initiatives and Future, ed. Wambugu, F. and Kamanga, D.. Basel: Springer International Publishing Switzerland, pp. 197–205.CrossRefGoogle Scholar
Ladisch, M. R. and Kohlmann, K. L. (1992). Recombinant human insulin. Biotechnology Progress 8(6), 469–478.CrossRefGoogle ScholarPubMed
Lundvall, B.-A. (2010). National Innovation Systems: Toward a Theory of Innovation and Interactive Learning. Copenhagen: Anthem Press.Google Scholar
New Partnership for Africa's Development (2003). Comprehensive Africa Agriculture Development Programme (CAADP). Pretoria: New Partnership for Africa's Development.Google Scholar
Office of the Gene Technology Regulator (2005). Risk Analysis Framework. Canberra: Office of the Gene Technology Regulator.Google Scholar
Pingali, P. (2012). Green Revolution: impacts, limits, and the path ahead. Proceedings of the National Academy of Sciences of the USA 109(31), 12302–12308.Google Scholar
Pingali, P. and Raney, T. (2005). From the Green Revolution to the Gene Revolution: How Will the Poor Fare? Rome: Food and Agriculture Organization.Google Scholar
Sengooba, T. et al. (2005). Analysis of the Biosafety System in Uganda. Kampala: National Council for Science and Technology.Google Scholar
United Nations Department of Economic and Social Affairs Population Division (2015). World population prospects: the 2015 revision, key findings and advance tables. Working Paper No. ESA/P/WP.241.Google Scholar
- 1
- Cited by